Stronger Q1 Earnings, New Buyback Plan Might Change The Case For Investing In Melco (MLCO)
Melco Crown Entertainment Ltd Sponsored ADR MLCO | 0.00 |
- In late April 2026, Melco Resorts & Entertainment reported first-quarter results showing higher sales, revenue and net income year on year, alongside strong adjusted property EBITDA growth, while also completing a large multi-year share repurchase and authorizing a new US$500 million buyback program to run over three years.
- Investors also learned that Melco acquired full ownership of its key trademarks and cut planned 2026 capital expenditure to about US$425 million, moves that may influence future cash flow allocation between growth projects and shareholder returns.
- With these stronger quarterly earnings and the new US$500 million repurchase authorization, we’ll now examine how this news reshapes Melco’s investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Melco Resorts & Entertainment Investment Narrative Recap
To own Melco, you need to believe its focus on premium mass customers across Macau and newer markets can translate into durable earnings, despite competition and leverage. Right now, the key short term catalyst is how effectively Melco converts recovering visitation into higher mass gaming profitability, while the biggest risk remains its sizable debt load. The latest quarter’s higher revenue and net income, plus reduced 2026 capex, strengthen this catalyst but do not remove that balance sheet risk.
The new US$500 million three year share repurchase program is the announcement that most clearly ties into this earnings story. It sits alongside a completed multi year buyback that has already retired about 38% of shares under the prior plan, and it directly intersects with the catalyst of balance sheet reshaping. For investors, the interaction between continued repurchases, interest costs and future dividend plans will be important to watch from here.
Yet while buybacks and earnings are improving, investors should still be aware of how Melco’s substantial debt and interest burden could limit...
Melco Resorts & Entertainment’s narrative projects $5.7 billion revenue and $438.0 million earnings by 2028. This requires 4.1% yearly revenue growth and a $333.9 million earnings increase from $104.1 million today.
Uncover how Melco Resorts & Entertainment's forecasts yield a $10.92 fair value, a 100% upside to its current price.
Exploring Other Perspectives
Some analysts were already optimistic, penciling in earnings of about US$568.1 million by 2028, but if Macau margins stay competitive and capex elevated, that more bullish view may differ sharply from your own, especially now that Q1 2026 results and the new US$500 million buyback could prompt a rethink of how realistic those assumptions really are.
Explore 7 other fair value estimates on Melco Resorts & Entertainment - why the stock might be worth 48% less than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Melco Resorts & Entertainment research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Melco Resorts & Entertainment research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Melco Resorts & Entertainment's overall financial health at a glance.
Searching For A Fresh Perspective?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
- AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
